Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
Submitted by
admin
on August 22, 2017 - 12:08am
Source:
TheStreet.com
News Tags:
Mylan Labs
generics
EpiPens
Medicaid
Headline:
Mylan Can Focus on New Generics After EpiPen Medicaid Settlement
Do Not Allow Advertisers to Use My Personal information
